Collaborations Pharmaceuticals has a total of 12 patents globally, out of which 2 have been granted. Of these 12 patents, more than 75% patents are active. The United States of America is where Collaborations Pharmaceuticals has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Collaborations Pharmaceuticals.
Collaborations Pharmaceuticals was founded in 2015. Collaborations Pharmaceuticals is a preclinical pipeline company that develops novel therapies and conducts research and development for uncommon and undertreated diseases.
Do read about some of the most popular patents of Collaborations Pharmaceuticals which have been covered by us in this article and also you can find Collaborations Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Collaborations Pharmaceuticals patent portfolio.
How many patents does Collaborations Pharmaceuticals have?
Collaborations Pharmaceuticals has a total of 12 patents globally. These patents belong to 7 unique patent families. Out of 12 patents, 9 patents are active.
How Many Patents did Collaborations Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Collaborations Pharmaceuticals Applications Filed | Collaborations Pharmaceuticals Patents Granted |
| 2022 | 2 | – |
| 2021 | 4 | – |
| 2020 | 5 | 1 |
| 2018 | 1 | 1 |
How many Collaborations Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Collaborations Pharmaceuticals File in Different Countries?
Countries in which Collaborations Pharmaceuticals Filed Patents
| Country | Patent |
| United States Of America | 4 |
| Europe | 2 |
| Canada | 1 |
Where are Research Centers of Collaborations Pharmaceuticals Patents Located?
10 Best Collaborations Pharmaceuticals Patents
WO2022061019A1, WO2021062189A1 is the most popular patent in the Collaborations Pharmaceuticals portfolio and it has received 1 citation.
What Percentage of Collaborations Pharmaceuticals US Patent Applications Were Granted?
Collaborations Pharmaceuticals (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.
Below are the key stats of Collaborations Pharmaceuticals patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Collaborations Pharmaceuticals?
| Law Firm | Total Applications | Success Rate |
| Epa Bozicevic Field & Francis Llp | 1 | 100% |
| Jenkins Wilson Taylor & Hunt P A | 1 | 0% |
List of Collaborations Pharmaceuticals patents
| Collaborations Pharmaceuticals Patents | Title |
| US11696914B1 | Use Of Pyronaridine, Tilorone, And Quinacrine Against Marburg Virus And Other Virus Infections |
| US11382875B2 | Methods And Compositions For Modulating Β-Amyloid/Α7-Nachr Interactions |
| US20230330045A1 | The Antiviral Drug Tilorone Is A Potent And Selective Inhibitor Of Acetylcholinesterase |
| US20220298149A1 | Isoxazole-3-Carboxamide Derivatives And Their Use For Treatment Of Diseases Caused By Virus Infection |
| EP4025212A4 | Isoxazole-3-Carboxamide Derivatives And Their Use For Treatment Of Diseases Caused By Virus Infection |
| EP4208257A1 | The Antiviral Drug Tilorone Is A Potent And Selective Inhibitor Of Acetylcholinesterase |
| WO2023114945A3 | Vandetanib Reduces Inflammatory Cytokines And Ameliorates Covid-19 |
| WO2023128786A1 | New Antiviral Triazole Derivatives, Their Synthesis And Their Use For Treatment Of Mammalian Viral Infections |
| CA3152534A1 | Isoxazole-3-Carboxamide Derivatives And Their Use For Treatment Of Diseases Caused By Virus Infection |
| WO2022155597A3 | Uv-Vis Spectra Prediction |
| WO2022061019A1 | The Antiviral Drug Tilorone Is A Potent And Selective Inhibitor Of Acetylcholinesterase |
| WO2021062189A1 | Isoxazole-3-Carboxamide Derivatives And Their Use For Treatment Of Diseases Caused By Virus Infection |
What are Collaborations Pharmaceuticals key innovation segments?
What Technologies are Covered by Collaborations Pharmaceuticals?
The chart below distributes patents filed by Collaborations Pharmaceuticals